ABTAbbott Laboratories

Health care · Pharmaceuticals · NYSE

Abbott Laboratories is an Illinois corporation, incorporated in 1900. 10-K, Item 1

Employees: 115,000
Headquarters: Abbott Park, IL
CEO: Robert B. Ford
Next results: around Jan 21, 2027

RevenueFY2016–25 $44.3B+5.7% Highest in 10 years 10-K FY2025 · XBRL Net incomeFY2016–25 $6.5B−51.3% FY2024: $13.4B 10-K FY2025 · XBRL Free cash flowFY2016–25 $7.4B+16.4% FY2024: $6.4B 10-K FY2025 · XBRL Operating marginFY2016–25 18.2%+1.9 pts 14.5% in FY2016 10-K FY2025 · XBRL

What changed

10-K filed Feb 20, 2026 against Feb 21, 2025

Area	What changed	Source
Risk factors	5 new paragraphs, nothing like them in the previous 10-K	10-K Item 1A
Accounting checks	11 other checks clear	10-K · XBRL
Insiders	No open-market buys in the last 90 days	Form 4
Filings	4 in the last 30 days	EDGAR

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

What's new, in their words

10-K filed Feb 20, 2026

Paragraphs in Risk Factors that were not in the 10-K filed 2025-02-21. Quoted as filed.

Changes in geopolitical and macroeconomic conditions could negatively affect Abbott’s business, financial condition, and results of operations. As a global healthcare company with sales outside of the U.S. making up approximately 61 percent of Abbott’s net sales in 2025, Abbott’s business is subject to geopolitical and macroeconomic…
10-K, Item 1A

All 5 new paragraphs →

Accounting checks

latest 10-K

11 of 11 clear 0 worth a look. Checks, not verdicts.

✓
Receivables +14.5% vs revenue +5.7% (+8.8 pts)
✓
Cash from operations $9.6B vs net income $6.5B (FY ending 2025-12-31)
✓
Inventory +4.7% vs revenue +5.7% (-0.9 pts)
✓
Same auditor in both 10-Ks: Ernst & Young LLP
✓
No statement of substantial doubt about going concern
✓
No 8-K item 4.02 in the last 2 years
✓
No NT 10-K or NT 10-Q in the last 2 years
✓
The same matters as last year: Income taxes – Unrecognized tax benefits
✓
No sentence in the 10-K concludes that controls were not effective because of a material weakness
✓
No 8-K item 2.06 in the last 2 years
✓
No 8-K item 1.03 in the last 2 years

How each check works, with sources →

In the last 30 days

All filings →

Nov 4, 202610-Q Quarterly report (10-Q) period ended Sep 30, 2026
Oct 31, 2026SEC letter SEC asked 9 questions about Form 10-K for the Fiscal Year Ended December 31, 2020 letters 2021-09-21 to 2022-02-11 · Climate, Results discussion (MD&A), Legal and contingencies
Oct 21, 20268-K Quarterly results 8-K item 2.02
Oct 21, 20268-K Other events 8-K item 8.01

Get an email when this changes: new risk paragraphs, accounting items, insider purchases, a new 10-K or 10-Q. RSS feed

Work on ABT in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/ABT/export.csv") into a cell.